FIRST AMENDMENT TO MULTI-TARGET AGREEMENTMulti-Target Agreement • May 6th, 2013 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 6th, 2013 Company Industry JurisdictionThis First Amendment to Multi-Target Agreement (the “First Amendment”) is entered into and made effective as of the later date of the two signatures below (the “First Amendment Effective Date”), by and between ImmunoGen, Inc., a Massachusetts corporation (“ImmunoGen”), with its principal place of business at 830 Winter Street, Waltham, Massachusetts 02451, and Novartis Institutes for BioMedical Research, Inc., a Delaware corporation (“Novartis”), with its principal place of business at 250 Massachusetts Avenue, Cambridge, Massachusetts 02139. ImmunoGen and Novartis are sometimes each hereinafter referred to individually as a “Party” and collectively as the “Parties.”